You remember the Ebola scare of 2014 right? If not, this was a year when instead of our media (in the US) flipping out about sharks, or drought, or immigrants, or what ever... they were flipping out about ebola. The hysteria of the time was due to an outbreak of the disease in Africa and infections which were occurring in physicians who volunteered their time (and risked their lives) to help treat people there. The fact that people were returning home and a few being diagnosed with the disease sparked a media frenzy and their was non-stop discussion surrounding Ebola at this time (and not with out reason, Ebola is a frightening disease, a hemorrhagic fever, resulting in bleeding out of every orifice).
This "crisis" (and I put it in quotes because it was serious, but no reason for the hub bub that surrounded it, at least not outside of Africa, where there was actually a legitimate crisis, but that was not the focus of the media!) resulted in the scientific community shifting into high gear to find better ways to treat it. One of the potential findings that came about with in the next year was that the compound Sertraline Hydrochloride was potentially effective at helping to fight the ebola virus. You may actually be quite familiar with Sertraline Hydrochloride, however you are likely to know it by a different name... as the antidepressant Zoloft.
Today lets discuss Ebola and some recent work published in the journal Nature: Scientific Reports titled "High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona"Image Source 1, Image Source 2 The Worlds Most Recent Ebola Outbreak
Ebola is a frightening disease, it is a hemorrhagic fever which are diseases which cause you to... well... hemorrhage, aka bleed both internally and externally. They are very often fatal, in the case of Ebola, about 50% of contracted cases result in death... not great odds really. If there is on...